Radical Schedule Reduction Design And Construction Strategies For Life Sciences

By Mark Butler, President and Managing Director - Americas, IPS

Speed to market is always a critical design driver for labs and clean manufacturing facilities. This is especially true as the research community is focused on finding a vaccine for the novel coronavirus that causes COVID-19. As a result, laboratory leaders today are looking for innovative delivery solutions that will accelerate the design and construction process to achieve the radical schedule reductions required to get lifesaving products to the market and to the patients who need them. Below are insights into the challenges, solutions, and key considerations to optimize success when looking to radically reduce design and construction schedules for research lab projects.